NASDAQ · Healthcare · Biotechnology
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc. CEO Todd C. Brady · Market cap $101.6M.
$1.69
-0.03 · -1.46%
52w hi $6.1752w lo $1.07
Off 52w high 74.9%
60
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $9.67
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 19 | DOUGLAS RICHARD | Buy | 70,000 | $1.40 | +$98K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay